FMCQF — Fresenius Medical Care AG
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1333141 ·
Last close
$44.58
Market Cap
$11.86B
52W High
$56.24
52W Low
$42.00
ADV30
90
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 4,612,147,000 | 1,179,492,000 | 375,555,000 | 117,529,000 | 31,467,593,000 | 1,239,145,000 | 17,262,895,000 |
| Dec 2025 | 5,069,585,000 | 1,388,372,000 | 548,977,000 | 327,078,000 | 31,002,333,000 | 1,582,518,000 | 16,719,524,000 |
| Sep 2025 | 4,884,850,000 | 1,242,218,000 | 501,719,000 | 274,797,000 | 30,887,005,000 | 1,255,948,000 | 16,978,599,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,745,062,000
Investing CF
$-783,768,000
Financing CF
$-1,700,505,000
CapEx
$-959,675,000
Dividends Paid
$0
Buybacks
$-781,497,000
EPS Diluted TTM
$3.15
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$12,301,614,000
Inventory
$2,303,007,000
Receivables
$3,715,432,000
ST Investments
$384,196,000
EBIT TTM
$1,851,095,000
Pretax Income TTM
$1,469,101,000
Interest Exp TTM
$381,994,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,427,147,776
EBITDA
$2,721,596,928
Free Cash Flow
$2,022,340,224
Enterprise Value
$22,633,005,056
Total Cash
$1,061,251,008
Total Debt
$10,978,023,424
Shares Out
266,109,685
Trailing EPS
$3.86
Book Value
$54.89
ROE
8.5%
ROA
4.0%
Div Yield
3.93%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 19,627,602,000 | 1,826,824,000 | 978,367,000 | 31,002,333,000 | 16,719,524,000 | 13,309,832,000 | 2,680,999,000 |
| Dec 2024 | 19,335,909,000 | 1,467,380,000 | 537,913,000 | 33,566,579,000 | 17,798,066,000 | 14,576,563,000 | 2,386,144,000 |
| Dec 2023 | 19,453,617,000 | 1,476,644,000 | 498,997,000 | 33,929,808,000 | 19,103,273,000 | 13,620,261,000 | 2,628,801,000 |
| Dec 2022 | 19,398,017,000 | 1,454,734,000 | 673,405,000 | 35,754,114,000 | 20,304,935,000 | 13,989,453,000 | 2,167,379,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FMS | Fresenius Medical Care AG | $12.21B | $22.95 | — |
| EHC | Encompass Health Corp | $12.23B | $124.02 | — |
| DVA | DAVITA INC. | $11.36B | $178.07 | — |
| BTSG | BrightSpring Health Services, Inc. | $11.19B | $56.54 | — |
| ENSG | ENSIGN GROUP, INC | $10.28B | $176.36 | — |
News headlines (Yahoo Finance, 1h cache)
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership
2026-09-25 12:00 · Yahoo
FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk
2026-09-07 22:30 · Yahoo
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
2026-09-03 19:22 · Yahoo
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
2026-09-03 12:22 · Yahoo
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
2026-08-27 13:00 · Yahoo
Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript
2026-08-11 14:40 · Yahoo
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
2026-08-05 14:49 · Yahoo
Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns
2026-08-05 04:28 · Yahoo
Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?
2026-08-05 00:21 · Yahoo
Fresenius Medical Care AG & Co. KGaA Q2 2026 Earnings Call Summary
2026-08-04 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.